Acidic Silica Sol: Properties, Stability and Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Filler for Plastics: Benefits, Grades and Applications
  • Keywords: silica market trends
  • Published: 2026-11-20 02:10:39
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
The size of the particles greatly affects the interaction with epithelial cells, cellular absorption, and therefore their effectiveness [ 1, 10, 12 ]. Furthermore, the size also influences the leakage of the API [ 12 ]. It has been proven in vitro that epithelial permeability can be increased by decreasing the size [ 1, 12, 13, 24 ]. Zhang et al. also observed that the cellular uptake of MSNs occurred in a time-, concentration-, and size-dependent manner based on in vitro studies performed on Caco-2 cell lines (20 nm, 60 nm, 90 nm) [ 24 ]. Nevertheless, more complex findings were gained in vivo. Wang et al. compared differently sized nanoparticles in various elements (100 nm, 250 nm, 480 nm) [ 12 ]. Similarly, Lamson et al. compared MSNs with different sizes to observe the influence of the particle size on bioavailability (20-1200 nm) [ 13 ]. Larger particles (normally around 500 nm) show slower release of the API and can form a strong interaction with the cell membrane [ 12 ], but cellular uptake is limited owing to their large size [ 1, 12 ]. Smaller particles (below 100 nm) show weaker interaction with the cell membrane but exert superb cellular uptake owing to their small size [ 12 ]. On the other hand, the smaller particles can slowly diffuse through the mucin layer covering the surface of the intestinal mucosa, become trapped in it, and aggregate, further worsening the absorption [ 1, 12, 13 ]. Furthermore, the decreasing particle size leads to increased release rate, owing to the larger specific surface area and faster degradation of the particles [ 1, 12 ], which can lead to early leakage of the molecules, worsening their absorption [ 1, 12 ]. As the diameter increases, the rate of degradation and drug release kinetics decreases, so larger particles have a longer half-life [ 12 ].

Silica 99% Purity: Specifications, Grades and Typical Applications

Silica for Underfill: Submicron Spherical Silica Requirements and Selection
Experiments carried out to investigate the effect of physicochemical properties.
Silica for Optical Fiber: Purity Requirements and Manufacturing Role
One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
Silica for Thermal Insulation: Aerogel, Fumed Silica and Microporous Materials Compared
57. Narayan R., Nayak U.Y., Raichur A.M., Garg S. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10:118. doi: 10.3390/pharmaceutics10030118. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
Silica Price Forecast: What to Expect for 2026–2027
15. Hong X., Zhong X., Du G., Hou Y., Zhang Y., Zhang Z., Gong T., Zhang L., Sun X. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci. Adv. 2020;6:eaaz4462. doi: 10.1126/sciadv.aaz4462. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]

Respirable Crystalline Silica OSHA Standard: Exposure Limits and Compliance Requirements

What is silica (SiO₂)?

silica supplier China

What is the difference between fumed silica and precipitated silica?

fumed silica 380 m2/g 108. Vialpando M., Albertini B., Passerini N., Heyden Y.V., Rombaut P., Martens J.A., Mooter G.V.D. Agglomeration of mesoporous silica by melt and steam granulation: Part II: Screening of steam granulation process variables using a factorial design. J. Pharm. Sci. 2013;102:3978-3986. doi: 10.1002/jps.23699. [ DOI ] [ PubMed ] [ Google Scholar ]

What drives silica raw material prices?

precipitated silica supplier Ho et al. employed the Multiple-Path Particle Dosimetry (MPPD) model for aerosolization and determination of lung deposition of silver nanoparticles, which method may be broadened to other materials like mesoporous silica nanoparticles [ 87 ]. It suggests particle size (mean 18 nm), density, and generation approach as principal elements that determine aerosolization efficiency and inhaled dose. Simulations of airflow, diffusion, sedimentation, and impact through airway generations yield comparable alveolar deposition fractions for particles less than 100 nm in humans and rats. With the addition of species-specific parameters, such as respiratory rate, lung surface region, tidal volume, and finished with possible lobar- and airway-level analysis, the MPPD model makes realistic regional retention predictions. Given that mesoporous silica nanoparticles are of similar size and physicochemical properties, the same methodology can estimate their aerosolization and lung deposition. In summary, the MPPD model is a handy tool in the assessment of inhalation danger and in guiding the formulation of safer nanomaterials [ 87 ]. In another study, Ali et al. applied the MPPD model to simulate aerosolization and lung deposition of mesoporous silica nanoparticles [ 88 ]. Pre-characterized MSNs with pre-specified aerodynamic diameters were initially assessed through scanning mobility particle sizing to yield accurate size-distribution inputs. Asymmetric mouse airway geometry and physiological parameters such as respiratory rate, lung volume, and airflow were used in simulations that were approximated to provide a total lung deposition of about 45%, of which 37% was in the head, 27% in the tracheobronchial, and 36% in the pulmonary (alveolar) region. These predictions are in reasonable agreement with earlier in vivo findings, validating the model. MPPD analysis also indicated that smaller MSNs exhibit more alveolar deposition, with the larger particles being better in the upper airways. Through linking aerosolization efficiency (via size distribution and concentration) and regional deposition, this modeling approach orients optimization of nanoparticle size and generation techniques toward maximizing targeted lung delivery [ 88 ]. To achieve easier production of aerosols, the surface of nanoparticles is often provided with a polymer coating, thereby stabilizing their distribution and increasing dispersibility [ 56 ]. By lowering the particle size, deeper lung areas can be reached [ 25 ]. Particles smaller than 1 µm are capable of accumulating in the alveoli, but the ideal size range to achieve maximum efficiency is in the 200-500 nm range [ 25 ]. Nevertheless, another review cited that particle size in the range of 50-200 nm is ideal for maximizing drug localization by inhalation [ 89 ]. It has also been recommended that the perfect diameter is approximately 500 nm for phagocytosis by alveolar macrophages [ 89 ]. Li et al. nebulized PEI-PEG-coated MSNs (50 nm particle size) by standard nebulizers without compromising their structure, while keeping particles in their individual form within the water droplets [ 90 ]. The aerosol supplies convenient delivery of MSNs to all areas of the respiratory tract - nasal, tracheobronchial, and pulmonary - and they persist for a week following inhalation, mostly within alveolar macrophages. It offers intracellular targeted delivery of lung diseases without passing through the gastrointestinal and first-pass metabolism. In spite of decreased deep lung deposition in mice under nasal breathing, exposure is comparable to that of humans with inhalation. Toxicity tests revealed no tissue damage or inflammation, further supporting MSN inhalation as a safe and effective method for vast treatment of pulmonary diseases, feasible for clinical translation [ 90 ]. A study investigated the effect of surface chemistry on drug loading capacity, release kinetics, and antibiotic activity in pulmonary infections on S. aureus bacterial cultures [ 18 ]. The model drugs were isoniazid, rifampicin, and vancomycin. Remarkable absorption ability was observed only with thiol (-SH) grafted carriers for all the tested drugs [ 18 ]. The in vitro drug release study showed sustained, but limited release: the cumulative release of rifampicin was 78.5% after 12 days, estimated by antibiogram [ 18 ]. Interestingly, the MIC values of the MSN-drug complex were higher for the free drug, probably due to the delayed and incomplete release from the pores [ 18 ]. Wang et al. developed a polydopamine-coated MSN formulation co-loaded with Ziyuglycoside I and Oseltamivir for the treatment of viral pneumonia. Interestingly, in vitro and in vivo studies have demonstrated that this carrier provided immediate release of Oseltamivir (allows quick virus killing) but prolonged release of Ziyuglycoside I (cuts down the inflammatory response for a longer period) [ 62 ].

Cite this article: Silica Raw Materials News. "Monodisperse Silica Spheres: Size Control, Synthesis and Applications ." Published 2026-11-20 02:10:39. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.